Related Experiment Video
Updated: Sep 27, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Explore potential disease related metabolites based on latent factor model
Yongtian Wang1,2, Liran Juan3, Jiajie Peng4,5
1School of Computer Science, Northwestern Polytechnical University, Xi'an, China. wangyt@nwpu.edu.cn.
A new model, DLMPM, predicts disease-related metabolites using literature and disease data. This computational approach identifies potential metabolic signatures for diseases, aiding in understanding pathogenesis and clinical diagnosis.
Area of Science:
- Metabolomics
- Computational Biology
- Biomedical Informatics
Background:
- Metabolomics aids in discovering disease signatures and elucidating molecular mechanisms.
- Identifying disease-related metabolites is crucial for understanding pathogenesis and advancing clinical medicine.
Purpose of the Study:
- To develop a computational model for predicting potential associations between metabolites and diseases.
- To identify novel metabolic signatures linked to human diseases.
Main Methods:
- A disease and literature driven metabolism prediction model (DLMPM) was developed using a latent factor model.
- An association matrix was constructed using disease terms from various databases and metabolite mappings, completed using similarity measures.
- Matrix decomposition was employed to predict metabolite-disease associations.
Main Results:
- The DLMPM identified 1,406 direct associations and predicted 119,206 unknown associations between metabolites and diseases with 80.88% coverage.
- Model performance was validated on 19 diseases, achieving an average Area Under the Curve (AUC) of 82.33%.
Conclusions:
- The proposed DLMPM effectively predicts potential metabolite-disease pairs.
- The model demonstrates superior performance in prioritizing candidate disease-related metabolites compared to existing methods, offering valuable insights for researchers.
More Related Videos
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Drug Metabolism: Phase II Reactions
Drug Metabolism: Phase I Reactions